Charles R Drew University Master of Science and Clinica*

查尔斯·R·德鲁大学科学与临床硕士*

• 批准号: 6804598
• 负责人: THOMAS Toyokazu YOSHIKAWA
• 金额: $ 53.66万
• 依托单位: CHARLES R. DREW UNIVERSITY OF MED & SCI
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-09-30 至 2008-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6804598
• 关键词: clinical research; curriculum; education evaluation /planning; human subject; medical education; science education; university

DESCRIPTION (provided by applicant): In response to the RFA-AR-01-009 entitled "Clinical Research Education and Career Development in Minority Institutions", the Charles R. Drew University of Medicine and Science (Drew) is planning to establish a Master of Science in Clinical Research Degree Program (MSCR) through the College of Medicine. This program represents a dramatic advancement as it will become the first independent degree offered through the College of Medicine. Presently, the Doctor of Medicine degree is jointly conferred through Drew's affiliation with the UCLA School of Medicine. This program represents a new curriculum at Drew that will utilize faculty not only from Drew, but also from the affiliated UCLA institutions, including faculty teaching the recently funded UCLA K-30 Translational Research Curriculum Award. The overarching goal is to train qualified candidates in clinical research methodologies and to impart a unique understanding of the cultural and ethical issues that impact how clinical investigation can contribute to improving the health care of our diverse nation. The core curriculum includes areas such as epidemiology, biostatistics, clinical trials, pharmaco-genetics, research ethics, the communication of science, and grantsmanship. The specific aims of the MSCR Program at Drew are to: 1. Implement a new curriculum for patient-oriented research that has a particular emphasis on methodologies to address health disparities. 2. Increase the number of women and ethnic minority investigators well-trained in health disparities research. 3. Develop a cadre of well-trained clinician faculty who will pursue clinical research on diseases that disproportionately affects minority populations. 4. Continuously evaluate the processes and the initial objectives of the MSCR program and utilize these assessments to make ongoing programmatic improvements in consultation with NIH program officials.

描述（由申请人提供）： 为了响应题为“少数族裔机构的临床研究教育和职业发展”的 RFA-AR-01-009，查尔斯·R·德鲁医学与科学大学 (Drew) 计划通过医学院设立临床研究理学硕士学位课程 (MSCR)。该项目代表了巨大的进步，因为它将成为医学院提供的第一个独立学位。目前，医学博士学位是通过德鲁与加州大学洛杉矶分校医学院联合授予的。该项目代表了德鲁大学的新课程，不仅将利用德鲁大学的教师，还将利用加州大学洛杉矶分校附属机构的教师，包括教授最近资助的加州大学洛杉矶分校 K-30 转化研究课程奖的教师。总体目标是培训临床研究方法方面的合格候选人，并传授对影响临床研究如何为改善我们多元化国家的医疗保健做出贡献的文化和伦理问题的独特理解。核心课程包括流行病学、生物统计学、临床试验、药物遗传学、研究伦理学、科学传播和资助等领域。德鲁 MSCR 项目的具体目标是： 1. 实施以患者为导向的研究新课程，特别强调解决健康差异的方法。 2. 增加在健康差异研究方面接受过良好培训的女性和少数民族调查人员的数量。 3. 培养一支训练有素的临床医师队伍，对影响少数民族人口的疾病进行临床研究。 4. 持续评估 MSCR 计划的流程和初步目标，并与 NIH 计划官员协商，利用这些评估进行持续的计划改进。